Get a look at the Heart failure Guidelines Forum 2016’s program
Why a Heart Failure Guidelines Closed Forum?
The quality of research and development efforts made by manufacturers of pharmacological agents, biomarkers, and medical devices has obviously had a major impact on the position of these products in clinical guidelines on the management of heart failure. Conversely, the success and failure stories that inevitably accompany the release of new guidelines may be a source of inspiration for further research and development. And, ultimately, guidelines really shape clinical practice if doctors and their patients adopt them.
A better understanding of the processes involved in guidelines development will help companies that develop drugs, biomarkers, and devices to adapt and improve their research and development programmes for the future. This could also translate into earlier and more efficient development of diagnostic and therapeutic tools for patients.